TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 94 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q1 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $403,000 | -64.2% | 840,000 | 0.0% | 0.04% | -63.7% |
| Q1 2019 | $1,126,000 | +26.1% | 840,000 | +6.3% | 0.10% | +88.9% |
| Q4 2018 | $893,000 | -54.8% | 790,571 | +10.6% | 0.05% | -57.8% |
| Q3 2018 | $1,974,000 | -7.8% | 715,097 | +19.2% | 0.13% | -11.7% |
| Q2 2018 | $2,142,000 | +16.3% | 600,000 | 0.0% | 0.14% | -11.0% |
| Q1 2018 | $1,842,000 | – | 600,000 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 330,000 | $2,353,000 | 0.98% |
| EcoR1 Capital, LLC | 633,400 | $4,516,000 | 0.80% |
| DLD Asset Management, LP | 570,000 | $4,059,000 | 0.53% |
| Rhenman & Partners Asset Management AB | 300,000 | $2,139,000 | 0.31% |
| Eventide Asset Management | 600,000 | $4,278,000 | 0.27% |
| Tekla Capital Management LLC | 1,004,322 | $7,161,000 | 0.26% |
| Rock Springs Capital Management LP | 698,000 | $4,977,000 | 0.25% |
| DLD Asset Management, LP | 230,000 | $1,640,000 | 0.21% |
| Worth Venture Partners, LLC | 29,325 | $209,000 | 0.18% |
| Crestline Management, LP | 161,403 | $1,151,000 | 0.15% |